CIK 0001585364 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in L2 · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 4.3 B | 4.5 B |
| Net income (USD) | -1.4 B | -140.6 M |
| Diluted EPS (USD/shares) | -10.29 | -1.04 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-15 | 4 | FORM 4 | 2026-09-11 |
| 2026-09-15 | 4 | FORM 4 | 2026-09-11 |
| 2026-09-10 | 4 | FORM 4 | 2026-09-09 |
| 2026-09-08 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-27 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-23 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-15 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-15 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-14 | 3 | FORM 3 | 2026-06-30 |
| 2026-07-10 | 3 | FORM 3 | 2026-06-30 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-09 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-09 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-06 | 8-K/A | 8-K/A items 5.02,9.01 | 2026-06-07 |
| 2026-07-06 | 8-K | 8-K items 5.02 | 2026-06-29 |
| 2026-06-30 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-06-30 |
Forms on file (last 1,000): 4 550, 8-K 149, 3 41, 10-Q 32, SC 13G/A 29, 4/A 20, DEFA14A 16, 144 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PRGO (0.002 USD), /gw/filings/filings?ticker=PRGO&form=8-K, /gw/filings/facts?ticker=PRGO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange